Howland Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Howland Capital Management LLC

$2.26 Billion
Q3 2024

A detailed history of Howland Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Howland Capital Management LLC holds 1,258 shares of REGN stock, worth $930,932. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,258

Previous 1,315 4.33%

Holding current value

$930,932

Previous $1.38 Million 4.34%

% of portfolio

0.06%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $58,373 - $68,500	-57 Reduced 4.33%	1,258 $1.32 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $15,897 - $19,281	-18 Reduced 1.35%	1,315 $1.38 Million
Q4 2023 Jan 23, 2024	SELL	$775.18 - $881.7 $6,201 - $7,053	-8 Reduced 0.6%	1,333 $1.17 Million
Q3 2023 Oct 17, 2023	SELL	$692.45 - $844.37 $5,539 - $6,754	-8 Reduced 0.59%	1,341 $1.1 Million
Q2 2023 Jul 28, 2023	SELL	$700.03 - $830.35 $2,800 - $3,321	-4 Reduced 0.3%	1,349 $969,000
Q1 2023 May 05, 2023	SELL	$680.49 - $826.97 $56,480 - $68,638	-83 Reduced 5.78%	1,353 $1.11 Million
Q4 2022 Jan 30, 2023	SELL	$705.89 - $766.39 $28,235 - $30,655	-40 Reduced 2.71%	1,436 $1.04 Million
Q3 2022 Oct 17, 2022	BUY	$573.97 - $724.32 $305,352 - $385,338	532 Added 56.36%	1,476 $1.02 Million
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $8,225 - $11,082	-15 Reduced 1.56%	944 $558,000
Q1 2022 Apr 27, 2022	BUY	$595.12 - $698.43 $53,560 - $62,858	90 Added 10.36%	959 $670,000
Q4 2021 Jan 26, 2022	SELL	$543.48 - $670.97 $20,652 - $25,496	-38 Reduced 4.19%	869 $549,000
Q2 2021 Jul 28, 2021	SELL	$472.8 - $558.54 $2,364 - $2,792	-5 Reduced 0.55%	907 $507,000
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $41,545 - $50,982	93 Added 11.36%	912 $432,000
Q2 2020 Jul 15, 2020	SELL	$493.32 - $643.92 $29,599 - $38,635	-60 Reduced 6.83%	819 $511,000
Q1 2020 Apr 13, 2020	SELL	$336.18 - $494.43 $29,583 - $43,509	-88 Reduced 9.1%	879 $429,000
Q4 2019 Jan 23, 2020	BUY	$274.13 - $376.51 $265,083 - $364,085	967 New	967 $363,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History